Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,033,000
-7,000 (-0.67%)
At close: Aug 14, 2025, 3:30 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 73.52 trillion as of August 15, 2025. Its market cap has increased by 21.39% in one year.
Market Cap
73.52T
Enterprise Value
73.66T
Revenue
4.90T
Ranking
n/a
PE Ratio
57.46
Stock Price
1,033,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 73.52T, an increase of 671.67%. That is a compound annual growth rate of 26.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 73.52T | 8.85% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | 54.65T | 90.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 38.80T |
| ALTEOGEN | 24.00T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |
| HLB Co., Ltd. | 5,476.74B |